BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Begini P, Cox MC, Angeletti S, Gigante E, Baccini F, Fonzo MD, Fave GD, Marignani M. Effectiveness of entecavir in the management of acute hepatitis B developing in a patient with Hodgkin's lymphoma: A case report. Scandinavian Journal of Infectious Diseases 2011;43:750-2. [DOI: 10.3109/00365548.2011.574149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Mihăilă RG. Liver Involvement in Hodgkin's Lymphoma: Types of Injuries and Therapeutic Implications. IJPPE 2017;8:1-15. [DOI: 10.18052/www.scipress.com/ijppe.8.1] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Streinu-cercel A, Sandulescu O, Stefan M, Streinu-cercel A. Treatment with lamivudine and entecavir in severe acute hepatitis B. Indian Journal of Medical Microbiology 2016;34:166-72. [DOI: 10.4103/0255-0857.176837] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
3 Korean Association for the Study of the Liver. KASL clinical practice guidelines: management of chronic hepatitis B. Clin Mol Hepatol 2016;22:18-75. [PMID: 27044762 DOI: 10.3350/cmh.2016.22.1.18] [Cited by in Crossref: 115] [Cited by in F6Publishing: 135] [Article Influence: 19.2] [Reference Citation Analysis]
4 Korean Association for the Study of the Liver. KASL Clinical Practice Guidelines: Management of chronic hepatitis B. Clin Mol Hepatol. 2012;18:109-162. [PMID: 22893865 DOI: 10.3350/cmh.2012.18.2.109] [Cited by in Crossref: 109] [Cited by in F6Publishing: 126] [Article Influence: 10.9] [Reference Citation Analysis]